 Xerostomia is a common oral complication experienced by many cancer patients undergoing antineoplastic therapies. This condition is characterized by a dry mouth sensation due to reduced saliva production. It can cause significant discomfort and impairment of oral health, leading to poor quality of life. Several strategies have been implemented to manage this problem, including dietary modifications, medications, and other interventions such as saliva substitutes and artificial saliva. Despite these efforts, further research is needed to develop more effective methods of managing Xerostomia. This article was authored by Tainara Barbieri, Keone Claudia Dicosta, and Letitia De Freitas Cubaghera.